Cite
HARVARD Citation
Al-Fayoumi, S. et al. (n.d.). Comparative biomarker profiles of pacritinib, momelotinib, pexidartinib, and ruxolitinib using BioMAP Diversity PLUS panel. European journal of cancer. pp. S136-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Al-Fayoumi, S. et al. (n.d.). Comparative biomarker profiles of pacritinib, momelotinib, pexidartinib, and ruxolitinib using BioMAP Diversity PLUS panel. European journal of cancer. pp. S136-. [Online].